Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CordovaCannLVRLF +8.75% Gross Margin % is 29.32% as of Dec. 2025, which is 0% below its 10-year median of 29.40. The stock has 6 warning signs investors should review. Among 943 Drug Manufacturers companies, CordovaCann ranks worse than 81.55% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
CordovaCann had a gross margin of 29.32% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
CordovaCann Gross Margin % Related Terms
CordovaCann Gross Margin % Historical Data
* Premium members only.
The historical data trend for CordovaCann's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LVRLF vs BUDZ, CTTH, SBFM: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, CordovaCann's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CordovaCann Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CordovaCann's Gross Margin % distribution charts can be found below:
* The bar in red indicates where CordovaCann's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
CordovaCann (LVRLF) has a Gross Margin % of 29.32% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on CordovaCann and its competitors. This is near median its historical median of 29.40. Over the past decade, CordovaCann's Gross Margin % has ranged from 27.57 to 35.77. According to the industry distribution chart, CordovaCann ranks #769 out of 943 companies in the Drug Manufacturers industry, placing it in the top 81.5%.
Is CordovaCann's Gross Margin % too high?
CordovaCann's current Gross Margin % of 29.32% is near median its 10-year median of 29.40. Over the past 10 years, this metric has ranged from a low of 27.57 to a high of 35.77. The Drug Manufacturers industry median Gross Margin % is 48.54. CordovaCann's value of 29.32% is 39.6% below this industry median. Based on the distribution chart, CordovaCann ranks #769 out of 943 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does CordovaCann's Gross Margin % compare to BUDZ and CTTH?
According to the Drug Manufacturers industry distribution chart, CordovaCann ranks #769 out of 943 companies for Gross Margin %. This places CordovaCann in the lower half of its industry. The industry median Gross Margin % is 48.54. CordovaCann's value of 29.32% is 39.6% below this benchmark. Historically, CordovaCann's own Gross Margin % has ranged from 27.57 to 35.77 over the past decade. While the company's 10-year median is 29.40 vs. the industry median of 48.54, CordovaCann has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CordovaCann's current Gross Margin % of 29.32% is 39.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on CordovaCann and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CordovaCann's current Gross Margin % is 29.32%, which is near median its own 10-year median of 29.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CordovaCann stock overvalued right now?
Based on GuruFocus' analysis, CordovaCann (LVRLF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.08, compared to a current price of $0.03 — trading 56.5% below its estimated fair value. The current Gross Margin % is 29.32%, which is near median its 10-year median of 29.40 and 39.6% below the Drug Manufacturers industry median of 48.54. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For CordovaCann (LVRLF), the current Gross Margin % is 29.32% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CordovaCann Corp is a Canadian-domiciled company focused on building a diversified cannabis company. The company provides services and investment capital to the processing and production of vertical markets of the cannabis industry. It aims to accelerate retail growth, invest and scale branded products, and leverage excess capacity for white label manufacturing, to drive company profitability.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LVRLF has been successfully added to your 
